324 related articles for article (PubMed ID: 9640861)
1. [Diagnosis of human parvovirus B19 infection in nonimmune hydrops fetalis].
Lenkiewicz B; Roszkowski T; Grabarczyk P; Moraczewska Z; Brojer E; Zupańska B
Ginekol Pol; 1998 Apr; 69(4):175-81. PubMed ID: 9640861
[TBL] [Abstract][Full Text] [Related]
2. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops.
Enders M; Weidner A; Rosenthal T; Baisch C; Hedman L; Söderlund-Venermo M; Hedman K
J Infect Dis; 2008 Jan; 197(1):58-62. PubMed ID: 18171285
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic and therapy of a severe fetal parvovirus-B19-infection with persistence of viral DNA in the mothers blood but inconspicuous serological tests. Case report].
Stenner S; Enders G; Klee A; Eiden U; Weidner A; Gonser M
Z Geburtshilfe Neonatol; 2002; 206(3):102-6. PubMed ID: 12098826
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus as a differential diagnosis of hydrops fetalis in the first trimester.
Sohan K; Carroll S; Byrne D; Ashworth M; Soothill P
Fetal Diagn Ther; 2000; 15(4):234-6. PubMed ID: 10867486
[TBL] [Abstract][Full Text] [Related]
5. Serologic study of human parvovirus B19 infection in pregnancy in Japan.
Yaegashi N; Niinuma T; Chisaka H; Uehara S; Okamura K; Shinkawa O; Tsunoda A; Moffatt S; Sugamura K; Yajima A
J Infect; 1999 Jan; 38(1):30-5. PubMed ID: 10090504
[TBL] [Abstract][Full Text] [Related]
6. Human parvovirus B19: immunity of Greek females and prenatal investigation of hydrops fetalis.
Kyriazopoulou V; Simitsopoulou M; Bondis J; Diza E; Athanasiadis A; Frantzidou F; Souliou E
Eur J Obstet Gynecol Reprod Biol; 1997 Aug; 74(2):157-60. PubMed ID: 9306109
[TBL] [Abstract][Full Text] [Related]
7. [Anti-parvovirus B19 IgG antibody prevalence in pregnant women during antenatal follow-up and cases of non-immune hydropsis fetalis due to parvovirus B19, in the City of Rio de Janeiro].
da Silva AR; Nogueira SA; Alzeguir JC; da Costa MC; do Nascimento JP
Rev Soc Bras Med Trop; 2006; 39(5):467-72. PubMed ID: 17160325
[TBL] [Abstract][Full Text] [Related]
8. Frequency of parvovirus B19 infection in nonimmune hydrops fetalis and utility of three diagnostic methods.
Essary LR; Vnencak-Jones CL; Manning SS; Olson SJ; Johnson JE
Hum Pathol; 1998 Jul; 29(7):696-701. PubMed ID: 9670826
[TBL] [Abstract][Full Text] [Related]
9. A clinical and epidemiological study of human parvovirus B19 infection in fetal hydrops using PCR Southern blot hybridization and chemiluminescence detection.
Wattre P; Dewilde A; Subtil D; Andreoletti L; Thirion V
J Med Virol; 1998 Feb; 54(2):140-4. PubMed ID: 9496373
[TBL] [Abstract][Full Text] [Related]
10. [Hydrops fetalis caused by maternal Parvovirus B19 infection].
Sterniste W; Rosen A
Klin Wochenschr; 1991 Jan; 69(1):46-8. PubMed ID: 1850053
[TBL] [Abstract][Full Text] [Related]
11. [NEW APPROACH IN DIAGNOSTIC ALGORITHM OF AN INFECTIOUS AGENTS (PARVOVIRUS B19 AND CHLAMYDIA TRACHOMATIS) INVOLVED IN THE DEVELOPMENT OF PATHOLOGICAL PREGNANCY].
Voleva S; Ivanova S; Marinov B; Genova-Kalou P; Manolov V; Vasilev V
Akush Ginekol (Sofiia); 2016; 55(3):30-9. PubMed ID: 27514136
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
[TBL] [Abstract][Full Text] [Related]
13. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
[TBL] [Abstract][Full Text] [Related]
14. Severe nonimmune hydrops fetalis and congenital corneal opacification secondary to human parvovirus B19 infection. A case report.
Plachouras N; Stefanidis K; Andronikou S; Lolis D
J Reprod Med; 1999 Apr; 44(4):377-80. PubMed ID: 10319311
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
[TBL] [Abstract][Full Text] [Related]
16. Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum.
Dieck D; Schild RL; Hansmann M; Eis-Hübinger AM
Prenat Diagn; 1999 Dec; 19(12):1119-23. PubMed ID: 10590428
[TBL] [Abstract][Full Text] [Related]
17. Fetal parvovirus B19 infection in a twin pregnancy with 1 twin presenting with hydrops fetalis and the other asymptomatic: a case report.
Leung TN; Leung TY; Chan PK; Fung TY; Lau TK
J Reprod Med; 2007 May; 52(5):419-21. PubMed ID: 17583243
[TBL] [Abstract][Full Text] [Related]
18. Long term follow up of serostatus after maternofetal parvovirus B19 infection.
Dembinski J; Eis-Hübinger AM; Maar J; Schild R; Bartmann P
Arch Dis Child; 2003 Mar; 88(3):219-21. PubMed ID: 12598382
[TBL] [Abstract][Full Text] [Related]
19. Microsphere-Based IgM and IgG Avidity Assays for Human Parvovirus B19, Human Cytomegalovirus, and Toxoplasma gondii.
Wang Y; Hedman L; Nurmi V; Ziemele I; Perdomo MF; Söderlund-Venermo M; Hedman K
mSphere; 2020 Mar; 5(2):. PubMed ID: 32188754
[TBL] [Abstract][Full Text] [Related]
20. A study by means of a new assay of the relationship between an outbreak of erythema infectiosum and non-immune hydrops fetalis caused by human parvovirus B19.
Yaegashi N; Okamura K; Tsunoda A; Nakamura M; Sugamura K; Yajima A
J Infect; 1995 Nov; 31(3):195-200. PubMed ID: 8586838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
